CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: insect growth regulator
Accession: CHEBI:24851
browse the term
Definition: A growth regulator that inhibits the life cycle of an insect.
Synonyms: related_synonym: insect growth regulators
G
Acp5
acid phosphatase 5, tartrate resistant
multiple interactions decreases expression
EXP
azadirachtin inhibits the reaction [Estrogens deficiency results in increased expression of ACP5 mRNA] azadirachtin results in decreased expression of ACP5 mRNA
CTD
PMID:31225646
NCBI chr 9:22,038,023...22,047,042
Ensembl chr 9:22,038,023...22,047,007
G
Apaf1
apoptotic peptidase activating factor 1
increases expression
ISO
azadirachtin results in increased expression of APAF1 protein
CTD
PMID:20429769
NCBI chr10:90,825,173...90,918,688
Ensembl chr10:90,825,173...90,918,632
G
Bad
BCL2-associated agonist of cell death
increases expression
ISO
azadirachtin results in increased expression of BAD mRNA
CTD
PMID:20429769
NCBI chr19:6,919,229...6,929,273
Ensembl chr19:6,919,229...6,929,267
G
Bax
BCL2-associated X protein
increases expression
ISO
azadirachtin results in increased expression of BAX mRNA
CTD
PMID:20429769
NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322
G
Bcl2
B cell leukemia/lymphoma 2
decreases expression
ISO
azadirachtin results in decreased expression of BCL2 mRNA; azadirachtin results in decreased expression of BCL2 protein
CTD
PMID:20429769
NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
G
Bcl2l1
BCL2-like 1
decreases expression
ISO
azadirachtin results in decreased expression of BCL2L1 mRNA
CTD
PMID:20429769
NCBI chr 2:152,600,652...152,673,632
Ensembl chr 2:152,622,588...152,673,648
G
Bglap
bone gamma carboxyglutamate protein
multiple interactions
EXP
azadirachtin inhibits the reaction [Estrogens deficiency results in increased expression of BGLAP protein]
CTD
PMID:31225646
NCBI chr 3:88,290,802...88,291,773
Ensembl chr 3:88,290,808...88,291,771
G
Bid
BH3 interacting domain death agonist
increases expression
ISO
azadirachtin results in increased expression of BID mRNA
CTD
PMID:20429769
NCBI chr 6:120,870,080...120,894,074
Ensembl chr 6:120,868,891...120,893,814
G
Birc5
baculoviral IAP repeat-containing 5
decreases expression
ISO
azadirachtin results in decreased expression of BIRC5 protein
CTD
PMID:20429769
NCBI chr11:117,740,063...117,746,569
Ensembl chr11:117,740,077...117,746,569
G
Bmp2
bone morphogenetic protein 2
increases expression
EXP
azadirachtin results in increased expression of BMP2 mRNA; azadirachtin results in increased expression of BMP2 protein
CTD
PMID:31225646
NCBI chr 2:133,394,079...133,404,816
Ensembl chr 2:133,394,079...133,404,805
G
Casp3
caspase 3
increases expression
ISO
azadirachtin results in increased expression of CASP3 mRNA; azadirachtin results in increased expression of CASP3 protein
CTD
PMID:20429769
NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
G
Casp6
caspase 6
increases expression
ISO
azadirachtin results in increased expression of CASP6 protein
CTD
PMID:20429769
NCBI chr 3:129,695,064...129,707,761
Ensembl chr 3:129,695,074...129,707,752
G
Casp8
caspase 8
increases expression
ISO
azadirachtin results in increased expression of CASP8 protein
CTD
PMID:20429769
NCBI chr 1:58,834,553...58,886,663
Ensembl chr 1:58,834,533...58,886,662
G
Casp9
caspase 9
increases expression
ISO
azadirachtin results in increased expression of CASP9 mRNA; azadirachtin results in increased expression of CASP9 protein
CTD
PMID:20429769
NCBI chr 4:141,520,923...141,543,289
Ensembl chr 4:141,520,923...141,543,287
G
Ccnd1
cyclin D1
decreases expression
ISO
azadirachtin results in decreased expression of CCND1 mRNA
CTD
PMID:20429769
NCBI chr 7:144,483,668...144,493,568
Ensembl chr 7:144,483,668...144,493,662
G
Cdkn1a
cyclin dependent kinase inhibitor 1A
increases expression
ISO
azadirachtin results in increased expression of CDKN1A mRNA; azadirachtin results in increased expression of CDKN1A protein
CTD
PMID:20429769
NCBI chr17:29,309,953...29,319,696
Ensembl chr17:29,309,950...29,319,701
G
Cycs
cytochrome c, somatic
affects localization increases expression
ISO
azadirachtin affects the localization of CYCS protein azadirachtin results in increased expression of CYCS mRNA
CTD
PMID:20429769
NCBI chr 6:50,539,543...50,543,549
Ensembl chr 6:50,539,543...50,543,518
G
Esr1
estrogen receptor 1 (alpha)
affects binding multiple interactions increases expression
ISO EXP
azadirachtin binds to ESR1 protein 1,3-bis(4-hydroxyphenyl)-4-methyl-5-(4-(2-piperidinylethoxy)phenol)-1H-pyrazole inhibits the reaction [azadirachtin results in increased expression of ESR1 mRNA]; 1,3-bis(4-hydroxyphenyl)-4-methyl-5-(4-(2-piperidinylethoxy)phenol)-1H-pyrazole inhibits the reaction [azadirachtin results in increased expression of ESR1 protein]; azadirachtin inhibits the reaction [Estrogens deficiency results in decreased expression of ESR1 mRNA]; ESR1 protein promotes the reaction [azadirachtin results in increased expression of RUNX2 mRNA]; ESR1 protein promotes the reaction [azadirachtin results in increased expression of RUNX2 protein] azadirachtin results in increased expression of ESR1 mRNA; azadirachtin results in increased expression of ESR1 protein
CTD
PMID:31225646
NCBI chr10:4,561,989...4,955,633
Ensembl chr10:4,561,593...4,955,614
G
Esr2
estrogen receptor 2 (beta)
affects binding multiple interactions increases expression
ISO EXP
azadirachtin binds to ESR2 protein azadirachtin inhibits the reaction [Estrogens deficiency results in decreased expression of ESR2 mRNA] azadirachtin results in increased expression of ESR2 mRNA; azadirachtin results in increased expression of ESR2 protein
CTD
PMID:31225646
NCBI chr12:76,167,193...76,224,033
Ensembl chr12:76,167,193...76,224,033
G
Ikbkb
inhibitor of kappaB kinase beta
decreases expression
ISO
azadirachtin results in decreased expression of IKBKB protein
CTD
PMID:20429769
NCBI chr 8:23,149,228...23,196,605
Ensembl chr 8:23,149,228...23,196,605
G
Mapk1
mitogen-activated protein kinase 1
increases phosphorylation
EXP
azadirachtin results in increased phosphorylation of MAPK1 protein
CTD
PMID:31225646
NCBI chr16:16,801,246...16,865,317
Ensembl chr16:16,801,246...16,865,317
G
Mapk3
mitogen-activated protein kinase 3
increases phosphorylation
EXP
azadirachtin results in increased phosphorylation of MAPK3 protein
CTD
PMID:31225646
NCBI chr 7:126,358,798...126,364,988
Ensembl chr 7:126,358,773...126,364,991
G
Nfkb1
nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105
decreases expression
ISO
azadirachtin results in decreased expression of NFKB1 protein
CTD
PMID:20429769
NCBI chr 3:135,290,416...135,397,422
Ensembl chr 3:135,290,416...135,397,308
G
Nfkbia
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha
decreases expression
ISO
azadirachtin results in decreased expression of NFKBIA protein modified form
CTD
PMID:20429769
NCBI chr12:55,536,194...55,539,432
Ensembl chr12:55,536,195...55,539,432
G
Pcna
proliferating cell nuclear antigen
decreases expression
ISO
azadirachtin results in decreased expression of PCNA mRNA; azadirachtin results in decreased expression of PCNA protein
CTD
PMID:20429769
NCBI chr 2:132,091,206...132,095,100
Ensembl chr 2:132,091,082...132,095,234
G
Rela
v-rel reticuloendotheliosis viral oncogene homolog A (avian)
decreases expression
ISO
azadirachtin results in decreased expression of RELA protein
CTD
PMID:20429769
NCBI chr19:5,686,993...5,698,162
Ensembl chr19:5,687,511...5,698,158
G
Runx2
runt related transcription factor 2
multiple interactions increases expression
EXP
ESR1 protein promotes the reaction [azadirachtin results in increased expression of RUNX2 mRNA]; ESR1 protein promotes the reaction [azadirachtin results in increased expression of RUNX2 protein] azadirachtin results in increased expression of RUNX2 mRNA; azadirachtin results in increased expression of RUNX2 protein
CTD
PMID:31225646
NCBI chr17:44,806,873...45,125,518
Ensembl chr17:44,806,874...45,125,684
G
Smad1
SMAD family member 1
increases expression
EXP
azadirachtin results in increased expression of SMAD1 protein modified form
CTD
PMID:31225646
NCBI chr 8:80,065,024...80,126,057
Ensembl chr 8:80,065,024...80,126,147
G
Tnf
tumor necrosis factor
decreases expression
EXP
azadirachtin results in decreased expression of TNF mRNA
CTD
PMID:31225646
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
G
Tnfrsf11a
tumor necrosis factor receptor superfamily, member 11a, NFKB activator
decreases expression multiple interactions
EXP
azadirachtin results in decreased expression of TNFRSF11A mRNA azadirachtin inhibits the reaction [Estrogens deficiency results in increased expression of TNFRSF11A mRNA]
CTD
PMID:31225646
NCBI chr 1:105,708,443...105,777,172
Ensembl chr 1:105,708,443...105,775,709
G
Trp53
transformation related protein 53
increases expression
ISO
azadirachtin results in increased expression of TP53 mRNA; azadirachtin results in increased expression of TP53 protein
CTD
PMID:20429769
NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699
G
Aen
apoptosis enhancing nuclease
increases expression
ISO
buprofezin results in increased expression of AEN mRNA
CTD
PMID:36287832
NCBI chr 7:78,545,675...78,560,957
Ensembl chr 7:78,545,602...78,560,957
G
Aifm1
apoptosis-inducing factor, mitochondrion-associated 1
increases expression
ISO
buprofezin results in increased expression of AIFM1 mRNA
CTD
PMID:36287832
NCBI chr X:47,563,821...47,602,440
Ensembl chr X:47,563,821...47,602,440
G
Aifm3
apoptosis-inducing factor, mitochondrion-associated 3
increases expression
ISO
buprofezin results in increased expression of AIFM3 mRNA
CTD
PMID:36287832
NCBI chr16:17,307,418...17,325,349
Ensembl chr16:17,307,475...17,325,349
G
Ambra1
autophagy/beclin 1 regulator 1
increases expression
ISO
buprofezin results in increased expression of AMBRA1 mRNA
CTD
PMID:36287832
NCBI chr 2:91,560,464...91,749,194
Ensembl chr 2:91,560,479...91,749,194
G
Atg10
autophagy related 10
increases expression
ISO
buprofezin results in increased expression of ATG10 mRNA
CTD
PMID:36287832
NCBI chr13:91,083,467...91,372,189
Ensembl chr13:91,083,475...91,372,087
G
Atg12
autophagy related 12
increases expression
ISO
buprofezin results in increased expression of ATG12 mRNA
CTD
PMID:36287832
NCBI chr18:46,865,484...46,874,683
Ensembl chr18:46,863,211...46,874,647
G
Atg5
autophagy related 5
increases expression
ISO
buprofezin results in increased expression of ATG5 mRNA
CTD
PMID:36287832
NCBI chr10:44,144,325...44,240,295
Ensembl chr10:44,144,354...44,240,287
G
Atg7
autophagy related 7
increases expression
ISO
buprofezin results in increased expression of ATG7 mRNA
CTD
PMID:36287832
NCBI chr 6:114,620,075...114,837,565
Ensembl chr 6:114,620,058...114,837,575
G
Atp2b4
ATPase, Ca++ transporting, plasma membrane 4
decreases expression
ISO
buprofezin results in decreased expression of ATP2B4 mRNA
CTD
PMID:36287832
NCBI chr 1:133,630,416...133,728,755
Ensembl chr 1:133,627,195...133,728,779
G
Bax
BCL2-associated X protein
increases expression
ISO
buprofezin results in increased expression of BAX protein
CTD
PMID:36287832
NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322
G
Bcl2
B cell leukemia/lymphoma 2
decreases expression
ISO
buprofezin results in decreased expression of BCL2 mRNA; buprofezin results in decreased expression of BCL2 protein
CTD
PMID:36287832
NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
G
Becn1
beclin 1, autophagy related
increases expression
ISO
buprofezin results in increased expression of BECN1 protein
CTD
PMID:36287832
NCBI chr11:101,179,084...101,193,112
Ensembl chr11:101,176,778...101,193,112
G
Bok
BCL2-related ovarian killer
increases expression
ISO
buprofezin results in increased expression of BOK mRNA
CTD
PMID:36287832
NCBI chr 1:93,613,297...93,623,492
Ensembl chr 1:93,613,382...93,623,486
G
Caap1
caspase activity and apoptosis inhibitor 1
decreases expression
ISO
buprofezin results in decreased expression of CAAP1 mRNA
CTD
PMID:36287832
NCBI chr 4:94,388,318...94,445,033
Ensembl chr 4:94,388,318...94,445,033
G
Casp3
caspase 3
increases activity
ISO
buprofezin results in increased activity of CASP3 protein
CTD
PMID:36287832
NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
G
Casp9
caspase 9
increases activity
ISO
buprofezin results in increased activity of CASP9 protein
CTD
PMID:36287832
NCBI chr 4:141,520,923...141,543,289
Ensembl chr 4:141,520,923...141,543,287
G
Cat
catalase
decreases activity
EXP
buprofezin results in decreased activity of CAT protein
CTD
PMID:31199169
NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505
G
Cyct
cytochrome c, testis
increases localization
ISO
buprofezin results in increased localization of CYCT protein
CTD
PMID:36287832
NCBI chr 2:76,184,286...76,190,797
Ensembl chr 2:76,184,286...76,190,794
G
Got1
glutamic-oxaloacetic transaminase 1, soluble
increases expression
EXP
buprofezin results in increased expression of GOT1 protein
CTD
PMID:31199169
NCBI chr19:43,488,191...43,514,743
Ensembl chr19:43,488,191...43,513,044
G
Gpt
glutamic pyruvic transaminase, soluble
increases expression
EXP
buprofezin results in increased expression of GPT protein
CTD
PMID:31199169
NCBI chr15:76,580,926...76,583,875
Ensembl chr15:76,579,916...76,583,886
G
Map1lc3b
microtubule-associated protein 1 light chain 3 beta
multiple interactions
ISO
buprofezin results in increased lipidation of and results in increased localization of MAP1LC3B protein
CTD
PMID:36287832
NCBI chr 8:122,317,177...122,325,499
Ensembl chr 8:122,317,100...122,325,499
G
Nr1i3
nuclear receptor subfamily 1, group I, member 3
increases activity
ISO
buprofezin results in increased activity of NR1I3 protein
CTD
PMID:28927721
NCBI chr 1:171,041,503...171,046,414
Ensembl chr 1:171,041,539...171,048,270
G
Rara
retinoic acid receptor, alpha
increases activity
ISO
buprofezin results in increased activity of RARA protein
CTD
PMID:20143881
NCBI chr11:98,818,626...98,865,768
Ensembl chr11:98,818,644...98,865,768
G
Sod1
superoxide dismutase 1, soluble
decreases activity
EXP
buprofezin results in decreased activity of SOD1 protein
CTD
PMID:31199169
NCBI chr16:90,017,650...90,023,221
Ensembl chr16:90,017,642...90,023,217
G
Sqstm1
sequestosome 1
decreases expression
ISO
buprofezin results in decreased expression of SQSTM1 protein
CTD
PMID:36287832
NCBI chr11:50,090,979...50,105,303
Ensembl chr11:50,090,193...50,101,654
G
Triap1
TP53 regulated inhibitor of apoptosis 1
decreases expression
ISO
buprofezin results in decreased expression of TRIAP1 mRNA
CTD
PMID:36287832
NCBI chr 5:115,479,290...115,481,612
Ensembl chr 5:115,479,284...115,481,628
G
Cyp2a5
cytochrome P450, family 2, subfamily a, polypeptide 5
increases expression
ISO
chlorfluazuron results in increased expression of CYP2A6 mRNA
CTD
PMID:22310298
NCBI chr 7:26,534,764...26,542,689
Ensembl chr 7:26,534,730...26,542,973
G
Cyp2b10
cytochrome P450, family 2, subfamily b, polypeptide 10
increases expression increases activity
ISO
chlorfluazuron results in increased expression of CYP2B6 mRNA chlorfluazuron results in increased activity of CYP2B6 protein
CTD
PMID:22310298
NCBI chr 7:25,597,083...25,626,049
Ensembl chr 7:25,597,045...25,626,049
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
multiple interactions decreases activity
ISO
chlorfluazuron inhibits the reaction [CYP2E1 protein results in increased hydroxylation of Chlorzoxazone] chlorfluazuron results in decreased activity of CYP2E1 protein
CTD
PMID:22634058
NCBI chr 7:140,343,732...140,354,903
Ensembl chr 7:140,343,652...140,354,900
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
increases expression
ISO
Diflubenzuron results in increased expression of CYP1A1 protein
CTD
PMID:8812189
NCBI chr 9:57,595,211...57,611,107
Ensembl chr 9:57,595,211...57,611,107
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
affects binding
ISO
Diflubenzuron binds to CYP1A2 protein
CTD
PMID:32278787
NCBI chr 9:57,584,220...57,590,938
Ensembl chr 9:57,584,220...57,590,986
G
Nr1i2
nuclear receptor subfamily 1, group I, member 2
increases activity
ISO
Diflubenzuron results in increased activity of NR1I2 protein
CTD
PMID:16565514
NCBI chr16:38,068,711...38,115,211
Ensembl chr16:38,068,685...38,115,186
G
Abcb1a
ATP-binding cassette, sub-family B member 1A
multiple interactions decreases activity
ISO
fenoxycarb inhibits the reaction [ABCB1 protein results in increased transport of calcein AM] fenoxycarb results in decreased activity of ABCB1 protein
CTD
PMID:21783720
NCBI chr 5:8,617,091...8,798,575
Ensembl chr 5:8,710,077...8,798,575
G
Ache
acetylcholinesterase
decreases activity
ISO
fenoxycarb results in decreased activity of ACHE protein
CTD
PMID:14644616
NCBI chr 5:137,286,516...137,292,728
Ensembl chr 5:137,285,781...137,292,728
G
Chrna3
cholinergic receptor, nicotinic, alpha polypeptide 3
multiple interactions
ISO
fenoxycarb results in decreased activity of [CHRNA3 protein binds to CHRNB2 protein]; fenoxycarb results in decreased activity of [CHRNA3 protein binds to CHRNB4 protein]
CTD
PMID:14644616
NCBI chr 9:54,917,401...54,933,846
Ensembl chr 9:54,917,395...54,933,846
G
Chrna4
cholinergic receptor, nicotinic, alpha polypeptide 4
multiple interactions
ISO
fenoxycarb results in decreased activity of [CHRNA4 protein binds to CHRNB2 protein]; fenoxycarb results in decreased activity of [CHRNA4 protein binds to CHRNB4 protein]
CTD
PMID:14644616
NCBI chr 2:180,664,104...180,685,339
Ensembl chr 2:180,660,173...180,685,339
G
Chrnb2
cholinergic receptor nicotinic beta 2 subunit
multiple interactions
ISO
fenoxycarb results in decreased activity of [CHRNA3 protein binds to CHRNB2 protein]; fenoxycarb results in decreased activity of [CHRNA4 protein binds to CHRNB2 protein]
CTD
PMID:14644616
NCBI chr 3:89,660,755...89,671,939
Ensembl chr 3:89,653,502...89,671,939
G
Chrnb4
cholinergic receptor, nicotinic, beta polypeptide 4
multiple interactions
ISO
fenoxycarb results in decreased activity of [CHRNA3 protein binds to CHRNB4 protein]; fenoxycarb results in decreased activity of [CHRNA4 protein binds to CHRNB4 protein]
CTD
PMID:14644616
NCBI chr 9:54,935,438...54,956,236
Ensembl chr 9:54,935,438...54,956,063
G
Nr1i3
nuclear receptor subfamily 1, group I, member 3
increases activity
ISO
fenoxycarb results in increased activity of NR1I3 protein
CTD
PMID:28927721
NCBI chr 1:171,041,503...171,046,414
Ensembl chr 1:171,041,539...171,048,270
G
Akt1
thymoma viral proto-oncogene 1
increases phosphorylation multiple interactions
EXP
flufenoxuron results in increased phosphorylation of AKT1 protein 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [flufenoxuron results in increased phosphorylation of AKT1 protein]; pyrazolanthrone inhibits the reaction [flufenoxuron results in increased phosphorylation of AKT1 protein]
CTD
PMID:33771252
NCBI chr12:112,620,260...112,641,266
Ensembl chr12:112,620,255...112,641,318
G
Ar
androgen receptor
decreases expression
EXP
flufenoxuron results in decreased expression of AR mRNA
CTD
PMID:33771252
NCBI chr X:97,192,363...97,366,824
Ensembl chr X:97,192,375...97,366,821
G
Bad
BCL2-associated agonist of cell death
decreases phosphorylation
EXP
flufenoxuron results in decreased phosphorylation of BAD protein
CTD
PMID:33771252
NCBI chr19:6,919,229...6,929,273
Ensembl chr19:6,919,229...6,929,267
G
Bak1
BCL2-antagonist/killer 1
increases expression
EXP
flufenoxuron results in increased expression of BAK1 protein
CTD
PMID:33771252
NCBI chr17:27,238,786...27,247,601
Ensembl chr17:27,238,784...27,247,983
G
Bcl2l1
BCL2-like 1
decreases expression
EXP
flufenoxuron results in decreased expression of BCL2L1 protein
CTD
PMID:33771252
NCBI chr 2:152,600,652...152,673,632
Ensembl chr 2:152,622,588...152,673,648
G
Cyp17a1
cytochrome P450, family 17, subfamily a, polypeptide 1
increases expression
EXP
flufenoxuron results in increased expression of CYP17A1 mRNA
CTD
PMID:33771252
NCBI chr19:46,655,604...46,661,439
Ensembl chr19:46,655,604...46,661,611
G
Cyp19a1
cytochrome P450, family 19, subfamily a, polypeptide 1
increases expression
EXP
flufenoxuron results in increased expression of CYP19A1 mRNA
CTD
PMID:33771252
NCBI chr 9:54,073,221...54,175,448
Ensembl chr 9:54,073,221...54,175,394
G
Ddit3
DNA-damage inducible transcript 3
increases expression
EXP
flufenoxuron results in increased expression of DDIT3 protein
CTD
PMID:33771252
NCBI chr10:127,126,662...127,132,160
Ensembl chr10:127,126,643...127,132,157 Ensembl chr10:127,126,643...127,132,157
G
Eif2s1
eukaryotic translation initiation factor 2, subunit 1 alpha
increases phosphorylation
EXP
flufenoxuron results in increased phosphorylation of EIF2S1 protein
CTD
PMID:33771252
NCBI chr12:78,908,846...78,933,784
Ensembl chr12:78,908,593...78,933,784
G
Ern1
endoplasmic reticulum to nucleus signalling 1
increases expression
EXP
flufenoxuron results in increased expression of ERN1 protein
CTD
PMID:33771252
NCBI chr11:106,285,474...106,378,701
Ensembl chr11:106,285,476...106,378,678
G
Hsd17b1
hydroxysteroid (17-beta) dehydrogenase 1
decreases expression
EXP
flufenoxuron results in decreased expression of HSD17B1 mRNA
CTD
PMID:33771252
NCBI chr11:100,968,792...100,972,014
Ensembl chr11:100,969,237...100,971,353
G
Hsd17b3
hydroxysteroid (17-beta) dehydrogenase 3
increases expression
EXP
flufenoxuron results in increased expression of HSD17B3 mRNA
CTD
PMID:33771252
NCBI chr13:64,206,088...64,237,076
Ensembl chr13:64,206,080...64,237,044
G
Hspa9
heat shock protein 9
increases expression
EXP
flufenoxuron results in increased expression of HSPA9 protein
CTD
PMID:33771252
NCBI chr18:35,070,467...35,087,404
Ensembl chr18:35,070,467...35,087,410
G
Jun
jun proto-oncogene
decreases expression
EXP
flufenoxuron results in decreased expression of JUN mRNA
CTD
PMID:33771252
NCBI chr 4:94,937,273...94,940,459
Ensembl chr 4:94,937,271...94,940,459
G
Jund
jun D proto-oncogene
decreases expression
EXP
flufenoxuron results in decreased expression of JUND mRNA
CTD
PMID:33771252
NCBI chr 8:71,150,389...71,153,265
Ensembl chr 8:71,151,599...71,153,265
G
Mapk1
mitogen-activated protein kinase 1
multiple interactions increases phosphorylation
EXP
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [flufenoxuron results in increased phosphorylation of MAPK1 protein]; pyrazolanthrone inhibits the reaction [flufenoxuron results in increased phosphorylation of MAPK1 protein]; U 0126 inhibits the reaction [flufenoxuron results in increased phosphorylation of MAPK1 protein]
CTD
PMID:33771252
NCBI chr16:16,801,246...16,865,317
Ensembl chr16:16,801,246...16,865,317
G
Mapk3
mitogen-activated protein kinase 3
increases phosphorylation multiple interactions
EXP
flufenoxuron results in increased phosphorylation of MAPK3 protein 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [flufenoxuron results in increased phosphorylation of MAPK3 protein]; pyrazolanthrone inhibits the reaction [flufenoxuron results in increased phosphorylation of MAPK3 protein]; U 0126 inhibits the reaction [flufenoxuron results in increased phosphorylation of MAPK3 protein]
CTD
PMID:33771252
NCBI chr 7:126,358,798...126,364,988
Ensembl chr 7:126,358,773...126,364,991
G
Mapk8
mitogen-activated protein kinase 8
increases phosphorylation multiple interactions
EXP
flufenoxuron results in increased phosphorylation of MAPK8 protein 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [flufenoxuron results in increased phosphorylation of MAPK8 protein]; pyrazolanthrone inhibits the reaction [flufenoxuron results in increased phosphorylation of MAPK8 protein]; U 0126 inhibits the reaction [flufenoxuron results in increased phosphorylation of MAPK8 protein]
CTD
PMID:33771252
NCBI chr14:33,099,855...33,169,213
Ensembl chr14:33,099,855...33,169,115
G
Pcna
proliferating cell nuclear antigen
decreases expression
EXP
flufenoxuron results in decreased expression of PCNA protein
CTD
PMID:33771252
NCBI chr 2:132,091,206...132,095,100
Ensembl chr 2:132,091,082...132,095,234
G
Rmdn3
regulator of microtubule dynamics 3
increases expression
EXP
flufenoxuron results in increased expression of RMDN3 protein
CTD
PMID:33771252
NCBI chr 2:118,967,479...118,987,515
Ensembl chr 2:118,967,482...118,987,515
G
Rps6ka1
ribosomal protein S6 kinase polypeptide 1
decreases phosphorylation multiple interactions
EXP
flufenoxuron results in decreased phosphorylation of RPS6KA1 protein 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [flufenoxuron results in decreased phosphorylation of RPS6KA1 protein]; U 0126 inhibits the reaction [flufenoxuron results in decreased phosphorylation of RPS6KA1 protein]
CTD
PMID:33771252
NCBI chr 4:133,574,601...133,615,466
Ensembl chr 4:133,574,601...133,615,108
G
Rps6kb1
ribosomal protein S6 kinase, polypeptide 1
decreases phosphorylation multiple interactions
EXP
flufenoxuron results in decreased phosphorylation of RPS6KB1 protein 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [flufenoxuron results in decreased phosphorylation of RPS6KB1 protein]; pyrazolanthrone affects the reaction [flufenoxuron results in decreased phosphorylation of RPS6KB1 protein]; U 0126 inhibits the reaction [flufenoxuron results in decreased phosphorylation of RPS6KB1 protein]
CTD
PMID:33771252
NCBI chr11:86,389,695...86,435,711
Ensembl chr11:86,389,697...86,435,631
G
Sqstm1
sequestosome 1
increases phosphorylation
EXP
flufenoxuron results in increased phosphorylation of SQSTM1 protein
CTD
PMID:33771252
NCBI chr11:50,090,979...50,105,303
Ensembl chr11:50,090,193...50,101,654
G
Star
steroidogenic acute regulatory protein
increases expression
EXP
flufenoxuron results in increased expression of STAR mRNA
CTD
PMID:33771252
NCBI chr 8:26,298,502...26,306,010
Ensembl chr 8:26,296,583...26,306,010
G
Vapb
vesicle-associated membrane protein, associated protein B and C
increases expression
EXP
flufenoxuron results in increased expression of VAPB protein
CTD
PMID:33771252
NCBI chr 2:173,579,378...173,626,132
Ensembl chr 2:173,579,304...173,626,132
G
Vdac1
voltage-dependent anion channel 1
increases expression
EXP
flufenoxuron results in increased expression of VDAC1 protein
CTD
PMID:33771252
NCBI chr11:52,251,905...52,280,224
Ensembl chr11:52,251,687...52,280,224
G
Alb
albumin
decreases expression
ISO
hexafluoron results in decreased expression of ALB protein
CTD
PMID:34993831
NCBI chr 5:90,608,729...90,624,461
Ensembl chr 5:90,608,756...90,624,461
G
Bax
BCL2-associated X protein
increases expression
ISO
hexafluoron results in increased expression of BAX mRNA
CTD
PMID:35773501
NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322
G
Bcl2
B cell leukemia/lymphoma 2
decreases expression
ISO
hexafluoron results in decreased expression of BCL2 mRNA
CTD
PMID:35773501
NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
G
Casp3
caspase 3
increases expression
ISO
hexafluoron results in increased expression of CASP3 mRNA; hexafluoron results in increased expression of CASP3 protein
CTD
PMID:34993831 PMID:35773501
NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
G
Cat
catalase
decreases activity
ISO
hexafluoron results in decreased activity of CAT protein
CTD
PMID:35773501
NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505
G
Cyp2a5
cytochrome P450, family 2, subfamily a, polypeptide 5
increases expression
ISO
hexafluoron results in increased expression of CYP2A6 mRNA
CTD
PMID:22310298
NCBI chr 7:26,534,764...26,542,689
Ensembl chr 7:26,534,730...26,542,973
G
Cyp2b10
cytochrome P450, family 2, subfamily b, polypeptide 10
increases expression increases activity
ISO
hexafluoron results in increased expression of CYP2B6 mRNA hexafluoron results in increased activity of CYP2B6 protein
CTD
PMID:22310298
NCBI chr 7:25,597,083...25,626,049
Ensembl chr 7:25,597,045...25,626,049
G
Gpt
glutamic pyruvic transaminase, soluble
increases expression
ISO
hexafluoron results in increased expression of GPT protein
CTD
PMID:34993831
NCBI chr15:76,580,926...76,583,875
Ensembl chr15:76,579,916...76,583,886
G
Hmox1
heme oxygenase 1
increases expression
ISO
hexafluoron results in increased expression of HMOX1 mRNA
CTD
PMID:34993831
NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217
G
Keap1
kelch-like ECH-associated protein 1
decreases expression
ISO
hexafluoron results in decreased expression of KEAP1 mRNA
CTD
PMID:34993831
NCBI chr 9:21,141,026...21,150,628
Ensembl chr 9:21,141,026...21,150,657
G
Mapk8
mitogen-activated protein kinase 8
increases expression
ISO
hexafluoron results in increased expression of MAPK8 mRNA
CTD
PMID:34993831 PMID:35773501
NCBI chr14:33,099,855...33,169,213
Ensembl chr14:33,099,855...33,169,115
G
Tnf
tumor necrosis factor
increases expression
ISO
hexafluoron results in increased expression of TNF protein
CTD
PMID:34993831
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
G
Rxra
retinoid X receptor alpha
multiple interactions
ISO EXP
Methoprene binds to and results in increased activity of RXRA protein
CTD
PMID:16731579
NCBI chr 2:27,566,457...27,653,331
Ensembl chr 2:27,566,452...27,652,969
G
Rxrb
retinoid X receptor beta
multiple interactions
ISO
Methoprene binds to and results in increased activity of RXRB protein
CTD
PMID:12970175
NCBI chr17:34,250,786...34,257,377
Ensembl chr17:34,250,786...34,257,373
G
Ucp1
uncoupling protein 1 (mitochondrial, proton carrier)
increases expression
EXP
Methoprene results in increased expression of UCP1 mRNA
CTD
PMID:10600643
NCBI chr 8:84,016,977...84,025,085
Ensembl chr 8:84,016,981...84,025,081
G
Abcb1a
ATP-binding cassette, sub-family B member 1A
multiple interactions increases transport
ISO
methoxyfenozide inhibits the reaction [ABCB1 protein results in increased transport of Quinidine] ABCB1 protein results in increased transport of methoxyfenozide
CTD
PMID:26995013
NCBI chr 5:8,617,091...8,798,575
Ensembl chr 5:8,710,077...8,798,575
G
Casp3
caspase 3
increases expression
EXP
pyriproxyfen metabolite results in increased expression of CASP3 protein
CTD
PMID:34289950
NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
G
Dlx2
distal-less homeobox 2
multiple interactions increases expression
EXP
[pyriproxyfen metabolite co-treated with Triiodothyronine] results in increased expression of DLX2 mRNA pyriproxyfen metabolite results in increased expression of DLX2 mRNA
CTD
PMID:34289950
NCBI chr 2:71,373,752...71,377,095
Ensembl chr 2:71,373,752...71,377,098
G
Fasn
fatty acid synthase
multiple interactions increases expression
EXP
[pyriproxyfen metabolite co-treated with Triiodothyronine] results in increased expression of FASN mRNA pyriproxyfen metabolite results in increased expression of FASN mRNA
CTD
PMID:34289950
NCBI chr11:120,696,784...120,715,992
Ensembl chr11:120,696,672...120,715,373
G
Msi1
musashi RNA-binding protein 1
increases expression multiple interactions
EXP
pyriproxyfen metabolite results in increased expression of MSI1 mRNA; pyriproxyfen metabolite results in increased expression of MSI1 protein [pyriproxyfen metabolite co-treated with Triiodothyronine] results in increased expression of MSI1 mRNA
CTD
PMID:34289950
NCBI chr 5:115,567,734...115,593,757
Ensembl chr 5:115,567,658...115,593,757
G
Nr1i3
nuclear receptor subfamily 1, group I, member 3
increases activity
ISO
pyriproxyfen results in increased activity of NR1I3 protein
CTD
PMID:28927721
NCBI chr 1:171,041,503...171,046,414
Ensembl chr 1:171,041,539...171,048,270
G
Sox10
SRY (sex determining region Y)-box 10
decreases expression multiple interactions
EXP
pyriproxyfen metabolite results in decreased expression of SOX10 mRNA [pyriproxyfen metabolite co-treated with Triiodothyronine] results in decreased expression of SOX10 mRNA
CTD
PMID:34289950
NCBI chr15:79,039,113...79,048,690
Ensembl chr15:79,039,108...79,049,440
G
Abcb1a
ATP-binding cassette, sub-family B member 1A
multiple interactions increases transport
ISO
tebufenozide inhibits the reaction [ABCB1 protein results in increased transport of Quinidine] ABCB1 protein results in increased transport of tebufenozide
CTD
PMID:26995013
NCBI chr 5:8,617,091...8,798,575
Ensembl chr 5:8,710,077...8,798,575
G
Cyp2a5
cytochrome P450, family 2, subfamily a, polypeptide 5
increases expression
ISO
tebufenozide results in increased expression of CYP2A6 mRNA
CTD
PMID:22310298
NCBI chr 7:26,534,764...26,542,689
Ensembl chr 7:26,534,730...26,542,973
G
Cyp2b10
cytochrome P450, family 2, subfamily b, polypeptide 10
increases expression
ISO
tebufenozide results in increased expression of CYP2B6 mRNA
CTD
PMID:22310298
NCBI chr 7:25,597,083...25,626,049
Ensembl chr 7:25,597,045...25,626,049
G
Cyp3a11
cytochrome P450, family 3, subfamily a, polypeptide 11
increases expression
EXP
tebufenozide results in increased expression of CYP3A11 mRNA
CTD
PMID:22310298
NCBI chr 5:145,791,417...145,816,664
Ensembl chr 5:145,791,236...145,816,774
G
Rorb
RAR-related orphan receptor beta
increases activity
ISO
tebufenozide results in increased activity of RORB protein
CTD
PMID:20143881
NCBI chr19:18,907,966...19,088,560
Ensembl chr19:18,907,969...19,088,560
G
Cat
catalase
increases activity
ISO
triflumuron results in increased activity of CAT protein
CTD
PMID:32312157
NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
increases metabolic processing
ISO
CYP1A1 protein results in increased metabolism of triflumuron
CTD
PMID:31082524
NCBI chr 9:57,595,211...57,611,107
Ensembl chr 9:57,595,211...57,611,107
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
multiple interactions increases metabolic processing
ISO
furafylline inhibits the reaction [CYP1A2 protein results in increased metabolism of triflumuron]
CTD
PMID:31082524
NCBI chr 9:57,584,220...57,590,938
Ensembl chr 9:57,584,220...57,590,986
G
Cyp2a5
cytochrome P450, family 2, subfamily a, polypeptide 5
increases metabolic processing
ISO
CYP2A6 protein results in increased metabolism of triflumuron
CTD
PMID:31082524
NCBI chr 7:26,534,764...26,542,689
Ensembl chr 7:26,534,730...26,542,973
G
Cyp2b10
cytochrome P450, family 2, subfamily b, polypeptide 10
increases metabolic processing
ISO
CYP2B6 protein results in increased metabolism of triflumuron
CTD
PMID:31082524
NCBI chr 7:25,597,083...25,626,049
Ensembl chr 7:25,597,045...25,626,049
G
Cyp2c29
cytochrome P450, family 2, subfamily c, polypeptide 29
increases metabolic processing
ISO
CYP2C8 protein results in increased metabolism of triflumuron
CTD
PMID:31082524
NCBI chr19:39,275,541...39,319,157
Ensembl chr19:39,257,849...39,319,157
G
Cyp2c38
cytochrome P450, family 2, subfamily c, polypeptide 38
multiple interactions increases metabolic processing
ISO
Sulfaphenazole inhibits the reaction [CYP2C19 protein results in increased metabolism of triflumuron]
CTD
PMID:31082524
NCBI chr19:39,379,109...39,451,519
Ensembl chr19:39,378,000...39,451,519
G
Cyp2c52-ps
cytochrome P450, family 2, subfamily c, polypeptide 52, pseudogene
increases metabolic processing
ISO
CYP2C18 protein results in increased metabolism of triflumuron
CTD
PMID:31082524
NCBI chr19:38,965,106...38,992,071
Ensembl chr19:38,965,091...38,991,733
G
Cyp2c65
cytochrome P450, family 2, subfamily c, polypeptide 65
increases metabolic processing
ISO
CYP2C9 protein results in increased metabolism of triflumuron
CTD
PMID:31082524
NCBI chr19:39,049,450...39,082,392
Ensembl chr19:39,049,459...39,082,388
G
Cyp2d22
cytochrome P450, family 2, subfamily d, polypeptide 22
increases metabolic processing
ISO
CYP2D6 protein results in increased metabolism of triflumuron
CTD
PMID:31082524
NCBI chr15:82,254,728...82,264,461
Ensembl chr15:82,254,728...82,264,461
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all